Endocrinopathies in patients with transfusion-dependent β-thalassemia

Pediatric Hematology and Oncology

Volumn 25, Issue 3, 2008, Pages 187-194

  Mehrvar, A ^a,g   Azarkeivan, A ^b   Faranoush, M ^c   Mehrvar, N ^d   Saberinedjad, J ^e   Ghorbani, R ^c   Vossough, P ^f  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e Army University of Medicine   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g NONE   (Iran)

Author keywords

Diabetes; Endocrine abnormality; Hypoparathyroidism; Hypothyroidism; Thalassemia

Indexed keywords

FERRITIN; HEMOGLOBIN A1C;

ADENOID; ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ENDOCRINE DISEASE; EXPERIMENT; FEMALE; GROUPS BY AGE; HEALTH CARE ORGANIZATION; HEALTH CENTER; HUMAN; HUMAN TISSUE; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IRAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RESEARCH; POPULATION; PREVALENCE; SAMPLE;

ADOLESCENT; ADULT; AGED; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; ORGAN SPECIFICITY; RETROSPECTIVE STUDIES; TRANSFERRIN;

EID: 42449123707     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010801938207     Document Type: Article

References (26)

1. Lee RG, Foester J, Lukens J, Paraskevas F, Greer JP, Rodger GM Wintrobe's Clinical Hematology, Vol. 1. Canada: Lippincott Williams & Wilkins; 1999:1407-1435.
2. Srivatsa A, Arivatsa A. Assessment of adrenal endocrine function in Asian thalassemics. Indian Pediatr. 2005;42:31-35.
3. Al-Elq AH, Al-Saeed HH. Endocrinopathies in patients with thalassemias. Saudi Med J. 2004;25:1347-1351.[Review]
4. Karamifar H, Shahriari M, Sadjadian N. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran. East Mediterr Health J. 2003;9:55-60.
5. Zervas A, Katopodi A, Protonotariou A, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid. 2002;12:151-154.
6. Aydinok Y, Darcan S, Polat A, et al. Endocrine complications in patients with beta-thalassemia major. J Trop Pediatr. 2002;48:50-54.
7. Tiosano D, Hochberg Z. Endocrine complications of thalassemia. J Endocrinol Invest. 2001;24:716-723.[Review]
8. Kattamis AC, Antoniadis M, Manoli I, Kitra V, Petropoulos D, Grafakos S. Endocrine problems in ex-thalassemic patients. Transfus Sci. 2000;23:251-252.
9. Zeitler PS, Travers S, Kappy MS. Advances in the recognition and treatment of endocrine complications in children with chronic illness. Adv Pediatr. 1999;46:101-149.[Review]
10. Mohammadian S, Bazrafshan HR, Sadeghi-Nejad A. Endocrine gland abnormalities in thalassemia major: a brief review. J Pediatr Endocrinol Metab. 2003;16:957-964.[Review]
11. Karagiorga-Lagana M. Fertility in thalassemia: the Greek experience. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):945-951.
12. De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res. 2002;58(Suppl 1):72-79.[Review]
13. De Sanctis V, Tangerini A, Testa MR, et al. Final height and endocrine function in thalassaemia intermedia. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):965-971.
14. Raiola G, Galati MC, De Sanctis V, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003;16(Suppl 2):259-266.[Review]
15. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab. 2000;13:651-656.
16. Lanzkowsky PH Manual of Pediatric Hematology and Ooncology. ed 3. New York: Academic Press; 2000:182-193.
17. Shamshirsaz A, Bakheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003;3:40.
18. Marshall W, Tanner J. Variations in the pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291.
19. Marshall W, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13.
20. Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics. 1999;104:936.
21. Biro FM, McMahon RP, Striegel-Moore R, et al. Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 2001;138:636.
22. Garn SM, LaVelle M, Rosenberg KR, Hawthorne VM. Maturational timing as a factor in female fatness and obesity. Am J Clin Nutr. 1986;43:879.
23. Abbassi V. Growth and normal puberty. Pediatrics. 1998;102:507.
24. Fung EB, Harmatz PR, Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006;135:574.
25. Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. Br J Haematol. 2006;134:438.
26. Multicentre study on prevalence of endocrine complications in thalassaemia major.. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Clin Endocrinol (Oxf). 1995;42:581.